The “Saatchi bill” is mistargeted and will put vulnerable patients at riskBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3135 (Published 14 May 2014) Cite this as: BMJ 2014;348:g3135
- Nigel Poole, barrister, Queen’s Counsel1
- 1Kings Chambers, Manchester M3 3FT, UK
The Medical Innovation Bill is unnecessary, mistargeted, and will put vulnerable patients at risk.1 In its response to the public consultation, the BMA said it “strongly believes that the draft bill should not become law.”2 I agree.
The bill’s laudable aim is to promote responsible medical innovation, but the draft on which the government has consulted seeks to do so by providing that doctors who …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial